Examples of using Non-specified in English and their translations into Portuguese
{-}
-
Colloquial
-
Official
-
Medicine
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
not even when subgroups like'acute','chronic lymphocytic','chronic myeloblastic' and'other non-specified types' were analyzed in separate.
related to the"other" and"non-specified" categories, the results found for certain substances cannot be representative
not to identify AS and Non-Specified Pervasive Developmental Disorders.
unknown and non-specified causes of morbidity, and diseases of the digestive system.
Pulmonary TB ICD-10: A162 and non-specified respiratory TB ICD-10:
with the first group suffering from viral meningitis and the other from non-specified bacteria meningitis.
meningococcal with meningococcemia and non-specified bacterial.
3% 9 non-specified causes, 2% 5 obstetrical causes, 1% 2 psychiatric causes.
428.1 left heart failure and 428.9 non-specified heart failure.
and other non-specified reasons.
as well as the 14.3% gathered together under the label of'non-specified workers.
other non-specified dementias, Parkinson's, or stroke motor sequelae had greater chances of institutionalization.
hemorrhagical type 9.8%, and non-specified type 28.
line C with E14.9 non-specified diabetes mellitus without complications,
only lagging behind other and non-specified drugs 42.1.
only lagging behind other and non-specified drugs 42.1.
Regarding the valve status at the beginning of the episode, 23 43% patients had prosthetic valves and 30 57% had native valves; two of these patients had native valves and patches for ventricular septal defect repair, and one had a biventricular assist device he was a candidate for cardiac transplantation due to a non-specified myocarditis.
11 presented bacterial growth, six being contaminated with non-specified coagulase-negative Staphylococcus five keyboards
staphylococcus coagulase negative bacteria, and by non-specified types of fungi.
of patients(approximately 63% IFN/placebo; 55% Avastin/IFN) received a variety of non-specified post-trial anti-cancer therapies,